
    
      Study groups:

      45 patients with chronic cough will be collected and two groups will formed based on
      diagnosis as follows:

      Group 1: EB group The patients with eosinophilic bronchitis received Bambuterol Hydrochloride
      tablets 10mg Q24 for three days .

      Group 2: CVA group The patients with cough variant asthma received Bambuterol Hydrochloride
      tablets 10mg Q24 for three days .

      Observe the response to Bambuterol Hydrochloride tablets treatment three days later and
      compare the effective rate of patients with EB and CVA. Then the study will be over.
    
  